Fiduciary Trust Co acquired a new position in shares of Relx Plc (NYSE:RELX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 5,207 shares of the technology company's stock, valued at approximately $237,000.
Several other hedge funds also recently made changes to their positions in the company. CENTRAL TRUST Co increased its holdings in shares of Relx by 1,290.2% in the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock valued at $26,000 after purchasing an additional 529 shares in the last quarter. Transce3nd LLC purchased a new position in Relx in the fourth quarter valued at about $40,000. Sierra Ocean LLC acquired a new stake in shares of Relx during the 4th quarter valued at approximately $43,000. Brown Brothers Harriman & Co. lifted its position in shares of Relx by 218.5% during the 4th quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock valued at $44,000 after acquiring an additional 662 shares during the period. Finally, Private Trust Co. NA boosted its stake in shares of Relx by 19.2% during the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock worth $56,000 after acquiring an additional 199 shares in the last quarter. Institutional investors and hedge funds own 15.02% of the company's stock.
Relx Price Performance
RELX stock traded up $0.49 on Friday, reaching $54.53. The company had a trading volume of 432,311 shares, compared to its average volume of 707,777. The company's fifty day moving average is $50.99 and its 200 day moving average is $48.84. The company has a market cap of $100.92 billion, a P/E ratio of 29.32, a PEG ratio of 2.73 and a beta of 0.86. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. Relx Plc has a 1 year low of $43.28 and a 1 year high of $55.21.
Relx Increases Dividend
The business also recently disclosed a semi-annual dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Friday, May 9th will be given a $0.5586 dividend. This is an increase from Relx's previous semi-annual dividend of $0.23. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, May 9th. Relx's dividend payout ratio is currently 59.68%.
Analyst Ratings Changes
RELX has been the subject of several research reports. Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a report on Wednesday, April 16th. StockNews.com downgraded Relx from a "buy" rating to a "hold" rating in a research note on Tuesday, March 4th. Barclays upgraded shares of Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. Finally, The Goldman Sachs Group started coverage on shares of Relx in a report on Wednesday, March 26th. They set a "buy" rating for the company. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Buy".
View Our Latest Report on Relx
Relx Company Profile
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Stories

Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.